Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017

Euro Surveill. 2018 Jan;23(3):17-00838. doi: 10.2807/1560-7917.ES.2018.23.3.17-00838.

Abstract

Tick-borne encephalitis virus (TBEV) is an important European vaccine-preventable pathogen. Discrimination of vaccine-induced antibodies from those elicited by infection is important. We studied anti-TBEV IgM/IgG responses, including avidity and neutralisation, by multiplex serology in 50 TBEV patients and 50 TBEV vaccinees. Infection induced antibodies reactive to both whole virus (WV) and non-structural protein 1 (NS1) in 48 clinical cases, whereas 47 TBEV vaccinees had WV, but not NS1 antibodies, enabling efficient discrimination of infection/vaccination.

Keywords: Tick-borne encephalitis (TBE); diagnostics; vaccine-preventable diseases; vaccines and immunisation; viral encephalitis; zoonotic infections.

MeSH terms

  • Antibodies, Viral / blood*
  • Encephalitis Viruses, Tick-Borne / genetics
  • Encephalitis Viruses, Tick-Borne / immunology*
  • Encephalitis Viruses, Tick-Borne / isolation & purification
  • Encephalitis, Tick-Borne / blood
  • Encephalitis, Tick-Borne / epidemiology
  • Encephalitis, Tick-Borne / prevention & control*
  • Encephalitis, Tick-Borne / virology*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Male
  • Sweden / epidemiology
  • Vaccination / statistics & numerical data*

Substances

  • Antibodies, Viral
  • Immunoglobulin G